Horizon Kinetics’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Horizon Kinetics's LLY Position: Q4 2018 in Review
Horizon Kinetics reduced its Eli Lilly (LLY) stake by 9.4% in Q4 2018, selling an estimated $223K and leaving 19,254 shares worth $2.23M. The position accounts for 0.07% of the portfolio, ranked #101.
Horizon Kinetics first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.56M in Q4 2015. 1,561 funds tracked by Wall St. Rank hold LLY as of Q4 2018.
- Horizon Kinetics held 19,254 shares of Eli Lilly worth $2.23M as of Q4 2018.
- Horizon Kinetics sold 2,000 Eli Lilly shares in Q4 2018, an estimated $223K.
- Eli Lilly made up 0.07% of Horizon Kinetics's portfolio in Q4 2018, its #101 holding.
- Horizon Kinetics first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- Horizon Kinetics's Eli Lilly position peaked at $2.56M in Q4 2015.
- 1,561 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.
Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.